0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global AI-Enabled Imaging Modalities Market Research Report 2026
Published Date: 2026-01-10
|
Report Code: QYRE-Auto-8Q4035
Home | Market Reports | Health| Medical Devices & Equipment
Global AI Enabled Imaging Modalities Market Size Status and Forecast 2021 2027
BUY CHAPTERS

Global AI-Enabled Imaging Modalities Market Research Report 2026

Code: QYRE-Auto-8Q4035
Report
2026-01-10
Pages:137
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

AI-Enabled Imaging Modalities Market Size

The global AI-Enabled Imaging Modalities market was valued at US$ 7480 million in 2025 and is anticipated to reach US$ 14750 million by 2032, at a CAGR of 10.5% from 2026 to 2032.

AI-Enabled Imaging Modalities Market

AI-Enabled Imaging Modalities Market

AI-supported medical imaging refers to hardware and software systems that utilize artificial intelligence technologies (such as deep learning and computer vision) to automatically analyze, detect lesions, quantitatively assess, and assist in the diagnosis of medical images such as X-rays, CT scans, MRIs, and ultrasounds. The aim is to improve the efficiency, accuracy, and standardization of image interpretation. The upstream of its industry chain includes medical imaging equipment manufacturers (such as GE, Siemens, and United Imaging), high-performance computing chips (GPUs/TPUs), and medical data storage and cloud computing service providers. The midstream consists of AI algorithm companies, medical imaging AI software developers, and system integrators. The downstream covers hospital radiology departments, health check-up centers, third-party imaging centers, and primary healthcare institutions. Commercialization is achieved through software licensing, SaaS subscriptions, or bundled sales with equipment. Due to high technological barriers, long clinical validation cycles, and strong compliance requirements, the gross profit margin of mature products generally remains between 60% and 85%, significantly higher than that of traditional medical software.
Currently, AI medical imaging has moved from technological research and development to an accelerated phase of clinical application, achieving large-scale application in areas such as pulmonary nodules, stroke, fractures, breast cancer, and liver diseases. China, the United States, and the European Union have successively established approval pathways for AI software in medical devices (such as NMPA Class III certificates and FDA SaMD) to promote compliant product launches. The industry is evolving from "single-disease-assisted detection" to "full-process intelligent workflow," deeply integrating into image acquisition, reconstruction, image interpretation, report generation, and follow-up management. At the same time, large-scale models (such as medical vision-language models) are emerging, driving breakthroughs in cross-modal analysis and general image understanding capabilities.
This report delivers a comprehensive overview of the global AI-Enabled Imaging Modalities market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding AI-Enabled Imaging Modalities. The AI-Enabled Imaging Modalities market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global AI-Enabled Imaging Modalities market comprehensively. Regional market sizes by Type, by Application, by AI Function, and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist AI-Enabled Imaging Modalities manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of AI-Enabled Imaging Modalities Market Report

Report Metric Details
Report Name AI-Enabled Imaging Modalities Market
Accounted market size in 2025 US$ 7480 million
Forecasted market size in 2032 US$ 14750 million
CAGR 10.5%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • AI-Enhanced X-ray
  • AI-Enhanced CT
  • AI-Enhanced MRI
  • AI-Enhanced Ultrasound
  • AI-Enhanced PET/SPECT
Segment by AI Function
  • Image Reconstruction & Denoising
  • Lesion Detection & Segmentation
  • Quantitative Analysis & Biomarker Extraction
  • Diagnostic Decision Support
  • Workflow Automation
Segment by Deployment Mode
  • On-Device AI Imaging
  • Cloud-Based AI Imaging
  • Hybrid AI Imaging Solutions
Segment by Application
  • Oncology Imaging
  • Cardiovascular Imaging
  • Neurology & Brain Imaging
  • Orthopedic & Musculoskeletal Imaging
  • Abdominal & Pulmonary Imaging
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Philips, Siemens Healthineers AG., GE HealthCare, Canon, Inc., Agfa HealthCare, Hologic, Fujifilm, Konica Minolta, Inc., United Health Imaging, Exo Imaging, Nanox, Butterfly Network, Inc., Hyperfine, Aidoc, MRIguidance, Synaptiq
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by AI Function, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
  • Chapter 3: Provides a detailed view of the competitive landscape for AI-Enabled Imaging Modalities companies, covering revenue share, development plans, and mergers and acquisitions.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
  • Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
  • Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
  • Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
  • Chapter 12: Key findings and conclusions of the report.

FAQ for this report

How fast is AI-Enabled Imaging Modalities Market growing?

Ans: The AI-Enabled Imaging Modalities Market witnessing a CAGR of 10.5% during the forecast period 2026-2032.

What is the AI-Enabled Imaging Modalities Market size in 2032?

Ans: The AI-Enabled Imaging Modalities Market size in 2032 will be US$ 14750 million.

Who are the main players in the AI-Enabled Imaging Modalities Market report?

Ans: The main players in the AI-Enabled Imaging Modalities Market are Philips, Siemens Healthineers AG., GE HealthCare, Canon, Inc., Agfa HealthCare, Hologic, Fujifilm, Konica Minolta, Inc., United Health Imaging, Exo Imaging, Nanox, Butterfly Network, Inc., Hyperfine, Aidoc, MRIguidance, Synaptiq

What are the Application segmentation covered in the AI-Enabled Imaging Modalities Market report?

Ans: The Applications covered in the AI-Enabled Imaging Modalities Market report are Oncology Imaging, Cardiovascular Imaging, Neurology & Brain Imaging, Orthopedic & Musculoskeletal Imaging, Abdominal & Pulmonary Imaging

What are the Type segmentation covered in the AI-Enabled Imaging Modalities Market report?

Ans: The Types covered in the AI-Enabled Imaging Modalities Market report are AI-Enhanced X-ray, AI-Enhanced CT, AI-Enhanced MRI, AI-Enhanced Ultrasound, AI-Enhanced PET/SPECT

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global AI-Enabled Imaging Modalities Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 AI-Enhanced X-ray
1.2.3 AI-Enhanced CT
1.2.4 AI-Enhanced MRI
1.2.5 AI-Enhanced Ultrasound
1.2.6 AI-Enhanced PET/SPECT
1.3 Market by AI Function
1.3.1 Global AI-Enabled Imaging Modalities Market Size Growth Rate by AI Function: 2021 vs 2025 vs 2032
1.3.2 Image Reconstruction & Denoising
1.3.3 Lesion Detection & Segmentation
1.3.4 Quantitative Analysis & Biomarker Extraction
1.3.5 Diagnostic Decision Support
1.3.6 Workflow Automation
1.4 Market by Deployment Mode
1.4.1 Global AI-Enabled Imaging Modalities Market Size Growth Rate by Deployment Mode: 2021 vs 2025 vs 2032
1.4.2 On-Device AI Imaging
1.4.3 Cloud-Based AI Imaging
1.4.4 Hybrid AI Imaging Solutions
1.5 Market by Application
1.5.1 Global AI-Enabled Imaging Modalities Market Growth by Application: 2021 vs 2025 vs 2032
1.5.2 Oncology Imaging
1.5.3 Cardiovascular Imaging
1.5.4 Neurology & Brain Imaging
1.5.5 Orthopedic & Musculoskeletal Imaging
1.5.6 Abdominal & Pulmonary Imaging
1.6 Assumptions and Limitations
1.7 Study Objectives
1.8 Years Considered
2 Global Growth Trends
2.1 Global AI-Enabled Imaging Modalities Market Perspective (2021–2032)
2.2 Global AI-Enabled Imaging Modalities Growth Trends by Region
2.2.1 Global AI-Enabled Imaging Modalities Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 AI-Enabled Imaging Modalities Historic Market Size by Region (2021–2026)
2.2.3 AI-Enabled Imaging Modalities Forecasted Market Size by Region (2027–2032)
2.3 AI-Enabled Imaging Modalities Market Dynamics
2.3.1 AI-Enabled Imaging Modalities Industry Trends
2.3.2 AI-Enabled Imaging Modalities Market Drivers
2.3.3 AI-Enabled Imaging Modalities Market Challenges
2.3.4 AI-Enabled Imaging Modalities Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top AI-Enabled Imaging Modalities Players by Revenue
3.1.1 Global Top AI-Enabled Imaging Modalities Players by Revenue (2021–2026)
3.1.2 Global AI-Enabled Imaging Modalities Revenue Market Share by Players (2021–2026)
3.2 Global Top AI-Enabled Imaging Modalities Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by AI-Enabled Imaging Modalities Revenue
3.4 Global AI-Enabled Imaging Modalities Market Concentration Ratio
3.4.1 Global AI-Enabled Imaging Modalities Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by AI-Enabled Imaging Modalities Revenue in 2025
3.5 Global Key Players of AI-Enabled Imaging Modalities Head Offices and Areas Served
3.6 Global Key Players of AI-Enabled Imaging Modalities, Products and Applications
3.7 Global Key Players of AI-Enabled Imaging Modalities, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 AI-Enabled Imaging Modalities Breakdown Data by Type
4.1 Global AI-Enabled Imaging Modalities Historic Market Size by Type (2021–2026)
4.2 Global AI-Enabled Imaging Modalities Forecasted Market Size by Type (2027–2032)
5 AI-Enabled Imaging Modalities Breakdown Data by Application
5.1 Global AI-Enabled Imaging Modalities Historic Market Size by Application (2021–2026)
5.2 Global AI-Enabled Imaging Modalities Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America AI-Enabled Imaging Modalities Market Size (2021–2032)
6.2 North America AI-Enabled Imaging Modalities Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America AI-Enabled Imaging Modalities Market Size by Country (2021–2026)
6.4 North America AI-Enabled Imaging Modalities Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe AI-Enabled Imaging Modalities Market Size (2021–2032)
7.2 Europe AI-Enabled Imaging Modalities Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe AI-Enabled Imaging Modalities Market Size by Country (2021–2026)
7.4 Europe AI-Enabled Imaging Modalities Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific AI-Enabled Imaging Modalities Market Size (2021–2032)
8.2 Asia-Pacific AI-Enabled Imaging Modalities Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific AI-Enabled Imaging Modalities Market Size by Region (2021–2026)
8.4 Asia-Pacific AI-Enabled Imaging Modalities Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America AI-Enabled Imaging Modalities Market Size (2021–2032)
9.2 Latin America AI-Enabled Imaging Modalities Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America AI-Enabled Imaging Modalities Market Size by Country (2021–2026)
9.4 Latin America AI-Enabled Imaging Modalities Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa AI-Enabled Imaging Modalities Market Size (2021–2032)
10.2 Middle East & Africa AI-Enabled Imaging Modalities Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa AI-Enabled Imaging Modalities Market Size by Country (2021–2026)
10.4 Middle East & Africa AI-Enabled Imaging Modalities Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Philips
11.1.1 Philips Company Details
11.1.2 Philips Business Overview
11.1.3 Philips AI-Enabled Imaging Modalities Introduction
11.1.4 Philips Revenue in AI-Enabled Imaging Modalities Business (2021–2026)
11.1.5 Philips Recent Development
11.2 Siemens Healthineers AG.
11.2.1 Siemens Healthineers AG. Company Details
11.2.2 Siemens Healthineers AG. Business Overview
11.2.3 Siemens Healthineers AG. AI-Enabled Imaging Modalities Introduction
11.2.4 Siemens Healthineers AG. Revenue in AI-Enabled Imaging Modalities Business (2021–2026)
11.2.5 Siemens Healthineers AG. Recent Development
11.3 GE HealthCare
11.3.1 GE HealthCare Company Details
11.3.2 GE HealthCare Business Overview
11.3.3 GE HealthCare AI-Enabled Imaging Modalities Introduction
11.3.4 GE HealthCare Revenue in AI-Enabled Imaging Modalities Business (2021–2026)
11.3.5 GE HealthCare Recent Development
11.4 Canon, Inc.
11.4.1 Canon, Inc. Company Details
11.4.2 Canon, Inc. Business Overview
11.4.3 Canon, Inc. AI-Enabled Imaging Modalities Introduction
11.4.4 Canon, Inc. Revenue in AI-Enabled Imaging Modalities Business (2021–2026)
11.4.5 Canon, Inc. Recent Development
11.5 Agfa HealthCare
11.5.1 Agfa HealthCare Company Details
11.5.2 Agfa HealthCare Business Overview
11.5.3 Agfa HealthCare AI-Enabled Imaging Modalities Introduction
11.5.4 Agfa HealthCare Revenue in AI-Enabled Imaging Modalities Business (2021–2026)
11.5.5 Agfa HealthCare Recent Development
11.6 Hologic
11.6.1 Hologic Company Details
11.6.2 Hologic Business Overview
11.6.3 Hologic AI-Enabled Imaging Modalities Introduction
11.6.4 Hologic Revenue in AI-Enabled Imaging Modalities Business (2021–2026)
11.6.5 Hologic Recent Development
11.7 Fujifilm
11.7.1 Fujifilm Company Details
11.7.2 Fujifilm Business Overview
11.7.3 Fujifilm AI-Enabled Imaging Modalities Introduction
11.7.4 Fujifilm Revenue in AI-Enabled Imaging Modalities Business (2021–2026)
11.7.5 Fujifilm Recent Development
11.8 Konica Minolta, Inc.
11.8.1 Konica Minolta, Inc. Company Details
11.8.2 Konica Minolta, Inc. Business Overview
11.8.3 Konica Minolta, Inc. AI-Enabled Imaging Modalities Introduction
11.8.4 Konica Minolta, Inc. Revenue in AI-Enabled Imaging Modalities Business (2021–2026)
11.8.5 Konica Minolta, Inc. Recent Development
11.9 United Health Imaging
11.9.1 United Health Imaging Company Details
11.9.2 United Health Imaging Business Overview
11.9.3 United Health Imaging AI-Enabled Imaging Modalities Introduction
11.9.4 United Health Imaging Revenue in AI-Enabled Imaging Modalities Business (2021–2026)
11.9.5 United Health Imaging Recent Development
11.10 Exo Imaging
11.10.1 Exo Imaging Company Details
11.10.2 Exo Imaging Business Overview
11.10.3 Exo Imaging AI-Enabled Imaging Modalities Introduction
11.10.4 Exo Imaging Revenue in AI-Enabled Imaging Modalities Business (2021–2026)
11.10.5 Exo Imaging Recent Development
11.11 Nanox
11.11.1 Nanox Company Details
11.11.2 Nanox Business Overview
11.11.3 Nanox AI-Enabled Imaging Modalities Introduction
11.11.4 Nanox Revenue in AI-Enabled Imaging Modalities Business (2021–2026)
11.11.5 Nanox Recent Development
11.12 Butterfly Network, Inc.
11.12.1 Butterfly Network, Inc. Company Details
11.12.2 Butterfly Network, Inc. Business Overview
11.12.3 Butterfly Network, Inc. AI-Enabled Imaging Modalities Introduction
11.12.4 Butterfly Network, Inc. Revenue in AI-Enabled Imaging Modalities Business (2021–2026)
11.12.5 Butterfly Network, Inc. Recent Development
11.13 Hyperfine
11.13.1 Hyperfine Company Details
11.13.2 Hyperfine Business Overview
11.13.3 Hyperfine AI-Enabled Imaging Modalities Introduction
11.13.4 Hyperfine Revenue in AI-Enabled Imaging Modalities Business (2021–2026)
11.13.5 Hyperfine Recent Development
11.14 Aidoc
11.14.1 Aidoc Company Details
11.14.2 Aidoc Business Overview
11.14.3 Aidoc AI-Enabled Imaging Modalities Introduction
11.14.4 Aidoc Revenue in AI-Enabled Imaging Modalities Business (2021–2026)
11.14.5 Aidoc Recent Development
11.15 MRIguidance
11.15.1 MRIguidance Company Details
11.15.2 MRIguidance Business Overview
11.15.3 MRIguidance AI-Enabled Imaging Modalities Introduction
11.15.4 MRIguidance Revenue in AI-Enabled Imaging Modalities Business (2021–2026)
11.15.5 MRIguidance Recent Development
11.16 Synaptiq
11.16.1 Synaptiq Company Details
11.16.2 Synaptiq Business Overview
11.16.3 Synaptiq AI-Enabled Imaging Modalities Introduction
11.16.4 Synaptiq Revenue in AI-Enabled Imaging Modalities Business (2021–2026)
11.16.5 Synaptiq Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global AI-Enabled Imaging Modalities Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
 Table 2. Key Players of AI-Enhanced X-ray
 Table 3. Key Players of AI-Enhanced CT
 Table 4. Key Players of AI-Enhanced MRI
 Table 5. Key Players of AI-Enhanced Ultrasound
 Table 6. Key Players of AI-Enhanced PET/SPECT
 Table 7. Global AI-Enabled Imaging Modalities Market Size Growth Rate by AI Function (US$ Million): 2021 vs 2025 vs 2032
 Table 8. Key Players of Image Reconstruction & Denoising
 Table 9. Key Players of Lesion Detection & Segmentation
 Table 10. Key Players of Quantitative Analysis & Biomarker Extraction
 Table 11. Key Players of Diagnostic Decision Support
 Table 12. Key Players of Workflow Automation
 Table 13. Global AI-Enabled Imaging Modalities Market Size Growth Rate by Deployment Mode (US$ Million): 2021 vs 2025 vs 2032
 Table 14. Key Players of On-Device AI Imaging
 Table 15. Key Players of Cloud-Based AI Imaging
 Table 16. Key Players of Hybrid AI Imaging Solutions
 Table 17. Global AI-Enabled Imaging Modalities Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
 Table 18. Global AI-Enabled Imaging Modalities Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 19. Global AI-Enabled Imaging Modalities Market Size by Region (US$ Million), 2021–2026
 Table 20. Global AI-Enabled Imaging Modalities Market Share by Region (2021–2026)
 Table 21. Global AI-Enabled Imaging Modalities Forecasted Market Size by Region (US$ Million), 2027–2032
 Table 22. Global AI-Enabled Imaging Modalities Market Share by Region (2027–2032)
 Table 23. AI-Enabled Imaging Modalities Market Trends
 Table 24. AI-Enabled Imaging Modalities Market Drivers
 Table 25. AI-Enabled Imaging Modalities Market Challenges
 Table 26. AI-Enabled Imaging Modalities Market Restraints
 Table 27. Global AI-Enabled Imaging Modalities Revenue by Players (US$ Million), 2021–2026
 Table 28. Global AI-Enabled Imaging Modalities Market Share by Players (2021–2026)
 Table 29. Global Top AI-Enabled Imaging Modalities Players by Tier (Tier 1, Tier 2, and Tier 3), based on AI-Enabled Imaging Modalities Revenue, 2025
 Table 30. Ranking of Global Top AI-Enabled Imaging Modalities Companies by Revenue (US$ Million) in 2025
 Table 31. Global 5 Largest Players Market Share by AI-Enabled Imaging Modalities Revenue (CR5 and HHI), 2021–2026
 Table 32. Global Key Players of AI-Enabled Imaging Modalities, Headquarters and Area Served
 Table 33. Global Key Players of AI-Enabled Imaging Modalities, Products and Applications
 Table 34. Global Key Players of AI-Enabled Imaging Modalities, Date of General Availability (GA)
 Table 35. Mergers and Acquisitions, Expansion Plans
 Table 36. Global AI-Enabled Imaging Modalities Market Size by Type (US$ Million), 2021–2026
 Table 37. Global AI-Enabled Imaging Modalities Revenue Market Share by Type (2021–2026)
 Table 38. Global AI-Enabled Imaging Modalities Forecasted Market Size by Type (US$ Million), 2027–2032
 Table 39. Global AI-Enabled Imaging Modalities Revenue Market Share by Type (2027–2032)
 Table 40. Global AI-Enabled Imaging Modalities Market Size by Application (US$ Million), 2021–2026
 Table 41. Global AI-Enabled Imaging Modalities Revenue Market Share by Application (2021–2026)
 Table 42. Global AI-Enabled Imaging Modalities Forecasted Market Size by Application (US$ Million), 2027–2032
 Table 43. Global AI-Enabled Imaging Modalities Revenue Market Share by Application (2027–2032)
 Table 44. North America AI-Enabled Imaging Modalities Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 45. North America AI-Enabled Imaging Modalities Market Size by Country (US$ Million), 2021–2026
 Table 46. North America AI-Enabled Imaging Modalities Market Size by Country (US$ Million), 2027–2032
 Table 47. Europe AI-Enabled Imaging Modalities Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 48. Europe AI-Enabled Imaging Modalities Market Size by Country (US$ Million), 2021–2026
 Table 49. Europe AI-Enabled Imaging Modalities Market Size by Country (US$ Million), 2027–2032
 Table 50. Asia-Pacific AI-Enabled Imaging Modalities Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 51. Asia-Pacific AI-Enabled Imaging Modalities Market Size by Region (US$ Million), 2021–2026
 Table 52. Asia-Pacific AI-Enabled Imaging Modalities Market Size by Region (US$ Million), 2027–2032
 Table 53. Latin America AI-Enabled Imaging Modalities Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 54. Latin America AI-Enabled Imaging Modalities Market Size by Country (US$ Million), 2021–2026
 Table 55. Latin America AI-Enabled Imaging Modalities Market Size by Country (US$ Million), 2027–2032
 Table 56. Middle East & Africa AI-Enabled Imaging Modalities Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 57. Middle East & Africa AI-Enabled Imaging Modalities Market Size by Country (US$ Million), 2021–2026
 Table 58. Middle East & Africa AI-Enabled Imaging Modalities Market Size by Country (US$ Million), 2027–2032
 Table 59. Philips Company Details
 Table 60. Philips Business Overview
 Table 61. Philips AI-Enabled Imaging Modalities Product
 Table 62. Philips Revenue in AI-Enabled Imaging Modalities Business (US$ Million), 2021–2026
 Table 63. Philips Recent Development
 Table 64. Siemens Healthineers AG. Company Details
 Table 65. Siemens Healthineers AG. Business Overview
 Table 66. Siemens Healthineers AG. AI-Enabled Imaging Modalities Product
 Table 67. Siemens Healthineers AG. Revenue in AI-Enabled Imaging Modalities Business (US$ Million), 2021–2026
 Table 68. Siemens Healthineers AG. Recent Development
 Table 69. GE HealthCare Company Details
 Table 70. GE HealthCare Business Overview
 Table 71. GE HealthCare AI-Enabled Imaging Modalities Product
 Table 72. GE HealthCare Revenue in AI-Enabled Imaging Modalities Business (US$ Million), 2021–2026
 Table 73. GE HealthCare Recent Development
 Table 74. Canon, Inc. Company Details
 Table 75. Canon, Inc. Business Overview
 Table 76. Canon, Inc. AI-Enabled Imaging Modalities Product
 Table 77. Canon, Inc. Revenue in AI-Enabled Imaging Modalities Business (US$ Million), 2021–2026
 Table 78. Canon, Inc. Recent Development
 Table 79. Agfa HealthCare Company Details
 Table 80. Agfa HealthCare Business Overview
 Table 81. Agfa HealthCare AI-Enabled Imaging Modalities Product
 Table 82. Agfa HealthCare Revenue in AI-Enabled Imaging Modalities Business (US$ Million), 2021–2026
 Table 83. Agfa HealthCare Recent Development
 Table 84. Hologic Company Details
 Table 85. Hologic Business Overview
 Table 86. Hologic AI-Enabled Imaging Modalities Product
 Table 87. Hologic Revenue in AI-Enabled Imaging Modalities Business (US$ Million), 2021–2026
 Table 88. Hologic Recent Development
 Table 89. Fujifilm Company Details
 Table 90. Fujifilm Business Overview
 Table 91. Fujifilm AI-Enabled Imaging Modalities Product
 Table 92. Fujifilm Revenue in AI-Enabled Imaging Modalities Business (US$ Million), 2021–2026
 Table 93. Fujifilm Recent Development
 Table 94. Konica Minolta, Inc. Company Details
 Table 95. Konica Minolta, Inc. Business Overview
 Table 96. Konica Minolta, Inc. AI-Enabled Imaging Modalities Product
 Table 97. Konica Minolta, Inc. Revenue in AI-Enabled Imaging Modalities Business (US$ Million), 2021–2026
 Table 98. Konica Minolta, Inc. Recent Development
 Table 99. United Health Imaging Company Details
 Table 100. United Health Imaging Business Overview
 Table 101. United Health Imaging AI-Enabled Imaging Modalities Product
 Table 102. United Health Imaging Revenue in AI-Enabled Imaging Modalities Business (US$ Million), 2021–2026
 Table 103. United Health Imaging Recent Development
 Table 104. Exo Imaging Company Details
 Table 105. Exo Imaging Business Overview
 Table 106. Exo Imaging AI-Enabled Imaging Modalities Product
 Table 107. Exo Imaging Revenue in AI-Enabled Imaging Modalities Business (US$ Million), 2021–2026
 Table 108. Exo Imaging Recent Development
 Table 109. Nanox Company Details
 Table 110. Nanox Business Overview
 Table 111. Nanox AI-Enabled Imaging Modalities Product
 Table 112. Nanox Revenue in AI-Enabled Imaging Modalities Business (US$ Million), 2021–2026
 Table 113. Nanox Recent Development
 Table 114. Butterfly Network, Inc. Company Details
 Table 115. Butterfly Network, Inc. Business Overview
 Table 116. Butterfly Network, Inc. AI-Enabled Imaging Modalities Product
 Table 117. Butterfly Network, Inc. Revenue in AI-Enabled Imaging Modalities Business (US$ Million), 2021–2026
 Table 118. Butterfly Network, Inc. Recent Development
 Table 119. Hyperfine Company Details
 Table 120. Hyperfine Business Overview
 Table 121. Hyperfine AI-Enabled Imaging Modalities Product
 Table 122. Hyperfine Revenue in AI-Enabled Imaging Modalities Business (US$ Million), 2021–2026
 Table 123. Hyperfine Recent Development
 Table 124. Aidoc Company Details
 Table 125. Aidoc Business Overview
 Table 126. Aidoc AI-Enabled Imaging Modalities Product
 Table 127. Aidoc Revenue in AI-Enabled Imaging Modalities Business (US$ Million), 2021–2026
 Table 128. Aidoc Recent Development
 Table 129. MRIguidance Company Details
 Table 130. MRIguidance Business Overview
 Table 131. MRIguidance AI-Enabled Imaging Modalities Product
 Table 132. MRIguidance Revenue in AI-Enabled Imaging Modalities Business (US$ Million), 2021–2026
 Table 133. MRIguidance Recent Development
 Table 134. Synaptiq Company Details
 Table 135. Synaptiq Business Overview
 Table 136. Synaptiq AI-Enabled Imaging Modalities Product
 Table 137. Synaptiq Revenue in AI-Enabled Imaging Modalities Business (US$ Million), 2021–2026
 Table 138. Synaptiq Recent Development
 Table 139. Research Programs/Design for This Report
 Table 140. Key Data Information from Secondary Sources
 Table 141. Key Data Information from Primary Sources
 Table 142. Authors List of This Report


List of Figures
 Figure 1. AI-Enabled Imaging Modalities Picture
 Figure 2. Global AI-Enabled Imaging Modalities Market Size Comparison by Type (US$ Million), 2021–2032
 Figure 3. Global AI-Enabled Imaging Modalities Market Share by Type: 2025 vs 2032
 Figure 4. AI-Enhanced X-ray Features
 Figure 5. AI-Enhanced CT Features
 Figure 6. AI-Enhanced MRI Features
 Figure 7. AI-Enhanced Ultrasound Features
 Figure 8. AI-Enhanced PET/SPECT Features
 Figure 9. Global AI-Enabled Imaging Modalities Market Size Comparison by AI Function (US$ Million), 2021–2032
 Figure 10. Image Reconstruction & Denoising Features
 Figure 11. Lesion Detection & Segmentation Features
 Figure 12. Quantitative Analysis & Biomarker Extraction Features
 Figure 13. Diagnostic Decision Support Features
 Figure 14. Workflow Automation Features
 Figure 15. Global AI-Enabled Imaging Modalities Market Size Comparison by Deployment Mode (US$ Million), 2021–2032
 Figure 16. On-Device AI Imaging Features
 Figure 17. Cloud-Based AI Imaging Features
 Figure 18. Hybrid AI Imaging Solutions Features
 Figure 19. Global AI-Enabled Imaging Modalities Market Size by Application (US$ Million), 2021–2032
 Figure 20. Global AI-Enabled Imaging Modalities Market Share by Application: 2025 vs 2032
 Figure 21. Oncology Imaging Case Studies
 Figure 22. Cardiovascular Imaging Case Studies
 Figure 23. Neurology & Brain Imaging Case Studies
 Figure 24. Orthopedic & Musculoskeletal Imaging Case Studies
 Figure 25. Abdominal & Pulmonary Imaging Case Studies
 Figure 26. AI-Enabled Imaging Modalities Report Years Considered
 Figure 27. Global AI-Enabled Imaging Modalities Market Size (US$ Million), Year-over-Year: 2021–2032
 Figure 28. Global AI-Enabled Imaging Modalities Market Size, (US$ Million), 2021 vs 2025 vs 2032
 Figure 29. Global AI-Enabled Imaging Modalities Market Share by Region: 2025 vs 2032
 Figure 30. Global AI-Enabled Imaging Modalities Market Share by Players in 2025
 Figure 31. Global AI-Enabled Imaging Modalities Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
 Figure 32. The Top 10 and 5 Players Market Share by AI-Enabled Imaging Modalities Revenue in 2025
 Figure 33. North America AI-Enabled Imaging Modalities Market Size YoY Growth (US$ Million), 2021–2032
 Figure 34. North America AI-Enabled Imaging Modalities Market Share by Country (2021–2032)
 Figure 35. United States AI-Enabled Imaging Modalities Market Size YoY Growth (US$ Million), 2021–2032
 Figure 36. Canada AI-Enabled Imaging Modalities Market Size YoY Growth (US$ Million), 2021–2032
 Figure 37. Europe AI-Enabled Imaging Modalities Market Size YoY Growth (US$ Million), 2021–2032
 Figure 38. Europe AI-Enabled Imaging Modalities Market Share by Country (2021–2032)
 Figure 39. Germany AI-Enabled Imaging Modalities Market Size YoY Growth (US$ Million), 2021–2032
 Figure 40. France AI-Enabled Imaging Modalities Market Size YoY Growth (US$ Million), 2021–2032
 Figure 41. U.K. AI-Enabled Imaging Modalities Market Size YoY Growth (US$ Million), 2021–2032
 Figure 42. Italy AI-Enabled Imaging Modalities Market Size YoY Growth (US$ Million), 2021–2032
 Figure 43. Russia AI-Enabled Imaging Modalities Market Size YoY Growth (US$ Million), 2021–2032
 Figure 44. Ireland AI-Enabled Imaging Modalities Market Size YoY Growth (US$ Million), 2021–2032
 Figure 45. Asia-Pacific AI-Enabled Imaging Modalities Market Size YoY Growth (US$ Million), 2021–2032
 Figure 46. Asia-Pacific AI-Enabled Imaging Modalities Market Share by Region (2021–2032)
 Figure 47. China AI-Enabled Imaging Modalities Market Size YoY Growth (US$ Million), 2021–2032
 Figure 48. Japan AI-Enabled Imaging Modalities Market Size YoY Growth (US$ Million), 2021–2032
 Figure 49. South Korea AI-Enabled Imaging Modalities Market Size YoY Growth (US$ Million), 2021–2032
 Figure 50. Southeast Asia AI-Enabled Imaging Modalities Market Size YoY Growth (US$ Million), 2021–2032
 Figure 51. India AI-Enabled Imaging Modalities Market Size YoY Growth (US$ Million), 2021–2032
 Figure 52. Australia & New Zealand AI-Enabled Imaging Modalities Market Size YoY Growth (US$ Million), 2021–2032
 Figure 53. Latin America AI-Enabled Imaging Modalities Market Size YoY Growth (US$ Million), 2021–2032
 Figure 54. Latin America AI-Enabled Imaging Modalities Market Share by Country (2021–2032)
 Figure 55. Mexico AI-Enabled Imaging Modalities Market Size YoY Growth (US$ Million), 2021–2032
 Figure 56. Brazil AI-Enabled Imaging Modalities Market Size YoY Growth (US$ Million), 2021–2032
 Figure 57. Middle East & Africa AI-Enabled Imaging Modalities Market Size YoY Growth (US$ Million), 2021–2032
 Figure 58. Middle East & Africa AI-Enabled Imaging Modalities Market Share by Country (2021–2032)
 Figure 59. Israel AI-Enabled Imaging Modalities Market Size YoY Growth (US$ Million), 2021–2032
 Figure 60. Saudi Arabia AI-Enabled Imaging Modalities Market Size YoY Growth (US$ Million), 2021–2032
 Figure 61. UAE AI-Enabled Imaging Modalities Market Size YoY Growth (US$ Million), 2021–2032
 Figure 62. Philips Revenue Growth Rate in AI-Enabled Imaging Modalities Business (2021–2026)
 Figure 63. Siemens Healthineers AG. Revenue Growth Rate in AI-Enabled Imaging Modalities Business (2021–2026)
 Figure 64. GE HealthCare Revenue Growth Rate in AI-Enabled Imaging Modalities Business (2021–2026)
 Figure 65. Canon, Inc. Revenue Growth Rate in AI-Enabled Imaging Modalities Business (2021–2026)
 Figure 66. Agfa HealthCare Revenue Growth Rate in AI-Enabled Imaging Modalities Business (2021–2026)
 Figure 67. Hologic Revenue Growth Rate in AI-Enabled Imaging Modalities Business (2021–2026)
 Figure 68. Fujifilm Revenue Growth Rate in AI-Enabled Imaging Modalities Business (2021–2026)
 Figure 69. Konica Minolta, Inc. Revenue Growth Rate in AI-Enabled Imaging Modalities Business (2021–2026)
 Figure 70. United Health Imaging Revenue Growth Rate in AI-Enabled Imaging Modalities Business (2021–2026)
 Figure 71. Exo Imaging Revenue Growth Rate in AI-Enabled Imaging Modalities Business (2021–2026)
 Figure 72. Nanox Revenue Growth Rate in AI-Enabled Imaging Modalities Business (2021–2026)
 Figure 73. Butterfly Network, Inc. Revenue Growth Rate in AI-Enabled Imaging Modalities Business (2021–2026)
 Figure 74. Hyperfine Revenue Growth Rate in AI-Enabled Imaging Modalities Business (2021–2026)
 Figure 75. Aidoc Revenue Growth Rate in AI-Enabled Imaging Modalities Business (2021–2026)
 Figure 76. MRIguidance Revenue Growth Rate in AI-Enabled Imaging Modalities Business (2021–2026)
 Figure 77. Synaptiq Revenue Growth Rate in AI-Enabled Imaging Modalities Business (2021–2026)
 Figure 78. Bottom-up and Top-down Approaches for This Report
 Figure 79. Data Triangulation
 Figure 80. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS